WNT9A Antibody | CSB-PA283200

(No reviews yet) Write a Review
SKU:
CSB-PA283200
Availability:
3 to 7 Working Days
  • WNT9A Antibody
  • Gel: 10%SDS-PAGE, Lysate: 50 μg, Lane: A549 cells, Primary antibody: CSB-PA283200 (WNT9A Antibody) at dilution 1/200, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 1 minute
€315.80 - €488.70

Description

WNT9A Antibody | CSB-PA283200 | Cusabio

WNT9A Antibody is Available at Gentaur Genprice with the fastest delivery.

Online Order Payment is possible or send quotation to info@gentaur.com.

Product Type: Polyclonal Antibody

Target Names: WNT9A

Aliases: Wingless-type MMTV integration site family, member 9A

Background: The WNT gene family consists of structurally related genes that encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis. This gene is a member of the WNT gene family. It is expressed in gastric cancer cell lines. The protein encoded by this gene shows 75% amino acid identity to chicken Wnt14, which has been shown to play a central role in initiating synovial joint formation in the chick limb. This gene is clustered with another family member, WNT3A, in the chromosome 1q42 region.

Isotype: IgG

Conjugate: Non-conjugated

Clonality: Polyclonal

Uniport ID: O14904

Host Species: Rabbit

Species Reactivity: Human, Mouse

Immunogen: Fusion protein of human WNT9A

Immunogen Species: Human

Applications: ELISA, WB

Tested Applications: ELISA, WB;ELISA:1:1000-1:2000, WB:1:200-1:1000

Purification Method: Antigen affinity purification

Dilution Ratio1: ELISA:1:1000-1:2000

Dilution Ratio2: WB:1:200-1:1000

Dilution Ratio3:

Dilution Ratio4:

Dilution Ratio5:

Dilution Ratio6:

Buffer: -20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol

Form: Liquid

Storage: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Initial Research Areas: Stem Cells

Research Areas: Cancer;Stem cells

View AllClose

0 Reviews

View AllClose